Inhibition of thromboxane formation prevents endotoxin-induced renal fibrin deposition in jaundiced rats.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood*; D000818:Animals; D004731:Endotoxins / Q000494:pharmacology*; D011464:Epoprostenol / Q000494:pharmacology; D005337:Fibrin / Q000502:physiology*; D007093:Imidazoles / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007565:Jaundice / Q000503:physiopathology*; D007668:Kidney / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013929:Thromboxane B2 / Q000097:blood*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors; D013931:Thromboxanes / Q000097:blood*
D004731:Endotoxins; D007093:Imidazoles; D013931:Thromboxanes; C029166:dazoxiben; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D005337:Fibrin; D011464:Epoprostenol; D013930:Thromboxane-A Synthase; D007213:Indomethacin